Heloisa P. Soares

Also affiliated with Huntsman Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

0.944Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome

Frontiers in Immunology(2023)10.3389/fimmu.2023.1229823

Top 21%

0.944DataRank

Top 21%26 citations

Jordan P. McPherson, Magdalena Kovacsovics-Bankowski, Joanne Jeter, Christos Vaklavas, Umang Swami +10 more

Papers

Driven by 15 papers — median percentile 79. Top paper: “A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome”.

A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome

Frontiers in Immunology(2023)10.3389/fimmu.2023.1229823

Top 21%

0.944DataRank

Top 21%26 citations

Jordan P. McPherson, Magdalena Kovacsovics-Bankowski, Joanne Jeter, Christos Vaklavas, Umang Swami +10 more

CYP2D6 ‐guided opioid therapy for adults with cancer pain: A randomized implementation clinical trial

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy(2023)10.1002/phar.2875

N/A

0.386DataRank · unranked

5 citations

Emily J. Cicali, Alex Del Cueto, Diane Portman, Kristine A. Donovan, Yan Gong +17 more

Genomic and Immune Correlates of EZH2 Expression and Activity in Olfactory Neuroblastoma

Head & Neck(2025)10.1002/hed.70076

N/A

0.104DataRank · unranked

1 citations

Tolulope Adeyelu, Harris B. Krause, Andrew Elliott, Ranee Mehra, Heloisa P. Soares +8 more

Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007440

N/A

0DataRank · unranked

14 citations

Charalampos S. Floudas, Asaf Maoz, Abdul Rafeh Naqash, Carter Norton, Aik Choon Tan +12 more

Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad096

N/A

0DataRank · unranked

9 citations

Thomas A. Hope, Emily B Bergsland, Lisa Bodei, David Bushnell, Jennifer A. Chan +63 more

Adaptation of a Multimedia Chemotherapy Educational Intervention for Latinos: Letting Patient Narratives Speak for Themselves

Journal of Cancer Education(2023)10.1007/s13187-023-02270-3

N/A

0DataRank · unranked

2 citations

Maria Teresa Bejarano Varas, Keysha Miralda, Yudy F. Muñeton‐Castaño, Grace Furtado, Anna Revette +8 more

Alliance A021804: A prospective, multi-institutional phase II trial evaluating temozolomide versus temozolomide and olaparib for advanced pheochromocytoma and paraganglioma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4191

N/A

0DataRank · unranked

5 citations

Kimberly Perez, Susan M. Geyer, Maged Khalil, Aishwarya Vijendran, Andrea Kordaris-Corkill +9 more

A phase 2 single-arm study of berzosertib in combination with irinotecan in patients with progressive TP53 mutant gastric and gastro-esophageal junction cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4044

N/A

0DataRank · unranked

4 citations

Heloisa P. Soares, Farshid Dayyani, Anwaar Saeed, Edward S. Kim, Ning Jin +7 more

Diagnostic performance of Cu64-dotatate-PET/CT or Ga68-dotatate-PET/CT with 18F-fluorodeoxyglucose (FDG)-PET/CT for neuroendocrine tumor evaluation.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.e16285

N/A

0DataRank · unranked

0 citations

Heloisa P. Soares, D.J. Kadrmas, Regan Butterfield, Zane G. Archibald, Sophie Stolk +5 more

KRAS Mutation Status and Treatment Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma

JAMA Network Open(2025)10.1001/jamanetworkopen.2024.53588

N/A

0DataRank · unranked

34 citations

Matthew Shaw, Zachary Rubnitz, Jarrod Smith, Heloisa P. Soares, Chris Nevala-Plagemann +3 more

Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting

Cancer Research Communications(2025)10.1158/2767-9764.crc-24-0501

N/A

0DataRank · unranked

14 citations

Andrew Elliott, Mark G. Evans, James Wacker, Kathleen M. Storey, Emily A. Egusa +14 more

Randomized phase II study of platinum and etoposide (EP) versus temozolomide and capecitabine (CAPTEM) in patients (pts) with advanced G3 non-small cell gastroenteropancreatic neuroendocrine neoplasms (GEPNENs): ECOG-ACRIN EA2142.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4020

N/A

0DataRank · unranked

13 citations

Paul J. Catalano, George A. Fisher, Daniel B. Rubin, Andrei Iagaru, David S. Klimstra +11 more

NCI 10211: a phase II, single-arm study of berzosertib in combination with irinotecan in patients with advanced TP53 mutant gastroesophageal cancer

The Oncologist(2025)10.1093/oncolo/oyaf400

N/A

0DataRank · unranked

0 citations

Shannon Stockton, Heloisa P. Soares, Farshid Dayyani, Anwaar Saeed, Edward Kim +12 more

Randomized phase II trial of postoperative adjuvant capecitabine and temozolomide versus observation in high-risk pancreatic neuroendocrine tumors: SWOG S2104.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps515

N/A

0DataRank · unranked

9 citations

Katherine A. Guthrie, Syed A. Ahmad, M. Kay Washington, Brian Hemendra Ramnaraign, Nitya Raj +8 more

Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3724

N/A

0DataRank · unranked

24 citations

Andrew Elliott, Matthew H. Bailey, David Stone, Kajsa E. Affolter, Heloisa P. Soares +9 more

Heloisa P. Soares

Indexed papers

Top data-sharing exemplar

Papers